600645 中源协和
已收盘 05-21 15:00:00
资讯
新帖
简况
中源协和(600645)披露2025年年度股东会决议公告,5月19日股价上涨0.9%
证券之星 · 05-19 18:10
中源协和(600645)披露2025年年度股东会决议公告,5月19日股价上涨0.9%
中源协和(600645)披露归还临时补充流动资金的募集资金公告,5月18日股价下跌1.81%
证券之星 · 05-18
中源协和(600645)披露归还临时补充流动资金的募集资金公告,5月18日股价下跌1.81%
每周股票复盘:中源协和(600645)将召开2025年年度股东会
证券之星 · 05-17
每周股票复盘:中源协和(600645)将召开2025年年度股东会
中源协和(600645)披露2025年年度股东会召开提示性公告,5月13日股价上涨0.12%
证券之星 · 05-13
中源协和(600645)披露2025年年度股东会召开提示性公告,5月13日股价上涨0.12%
中源协和(600645)披露关于计提资产减值损失的公告,4月27日股价下跌2.07%
证券之星 · 04-27
中源协和(600645)披露关于计提资产减值损失的公告,4月27日股价下跌2.07%
中源协和(600645)2026年一季报简析:净利润同比下降13.5%,盈利能力上升
证券之星 · 04-26
中源协和(600645)2026年一季报简析:净利润同比下降13.5%,盈利能力上升
每周股票复盘:中源协和(600645)一季度净利降13.5%
证券之星 · 04-26
每周股票复盘:中源协和(600645)一季度净利降13.5%
中源协和(600645)3月31日股东户数3.97万户,较上期增加12.34%
证券之星 · 04-25
中源协和(600645)3月31日股东户数3.97万户,较上期增加12.34%
图解中源协和年报:第四季度单季净利润同比增长117.87%
证券之星 · 04-25
图解中源协和年报:第四季度单季净利润同比增长117.87%
中源协和最新公告:第一季度净利润同比下降13.50%
证券之星 · 04-24
中源协和最新公告:第一季度净利润同比下降13.50%
中源协和(600645)披露全资子公司VUM02注射液临床试验进展公告,4月21日股价下跌2.87%
证券之星 · 04-21
中源协和(600645)披露全资子公司VUM02注射液临床试验进展公告,4月21日股价下跌2.87%
异动快报:中源协和(600645)4月3日14点9分触及跌停板
证券之星 · 04-03
异动快报:中源协和(600645)4月3日14点9分触及跌停板
异动快报:中源协和(600645)3月6日10点9分触及涨停板
证券之星 · 03-06
异动快报:中源协和(600645)3月6日10点9分触及涨停板
中源协和最新公告:子公司获医疗器械注册证产品为国内首款飞行时间质谱法肿瘤伴随诊断试剂盒
证券之星 · 03-01
中源协和最新公告:子公司获医疗器械注册证产品为国内首款飞行时间质谱法肿瘤伴随诊断试剂盒
1月5日中源协和涨6.11%,银河医药混合A基金重仓该股
证券之星 · 01-05
1月5日中源协和涨6.11%,银河医药混合A基金重仓该股
中国生物科技服务引入战略投资者龚虹嘉先生 开启产业协同与二次增长新篇章
智通财经 · 2025-12-31
中国生物科技服务引入战略投资者龚虹嘉先生 开启产业协同与二次增长新篇章
中源协和(600645)披露募投项目延期公告,12月25日股价上涨1.02%
证券之星 · 2025-12-25
中源协和(600645)披露募投项目延期公告,12月25日股价上涨1.02%
中源协和最新公告:终止与中国科学院大学教育基金会捐赠协议并解除合作协议
证券之星 · 2025-12-25
中源协和最新公告:终止与中国科学院大学教育基金会捐赠协议并解除合作协议
中源协和(600645)披露拟取消监事会并修订公司章程,11月27日股价下跌0.04%
证券之星 · 2025-11-27
中源协和(600645)披露拟取消监事会并修订公司章程,11月27日股价下跌0.04%
11月24日中源协和涨10.02%,银河医药混合A基金重仓该股
证券之星 · 2025-11-24
11月24日中源协和涨10.02%,银河医药混合A基金重仓该股
加载更多
公司概况
公司名称:
中源协和细胞基因工程股份有限公司
所属行业:
研究和试验发展
上市日期:
1993-05-04
主营业务:
中源协和细胞基因工程股份有限公司的主营业务是“精准预防”领域的细胞检测制备及存储;“精准诊断”领域的体外诊断原料、体外诊断试剂和器械的研产销,生物基因、蛋白、抗体等科研试剂产品,以及基因检测服务;“细胞治疗”领域的干细胞、免疫细胞临床应用的研发。公司的主要产品是细胞检测制备及存储、基因检测、科研试剂、检测试剂。
发行价格:
50.00
{"stockData":{"symbol":"600645","market":"SH","secType":"STK","nameCN":"中源协和","latestPrice":21.14,"timestamp":1779346801000,"preClose":21.78,"halted":0,"volume":9985538,"delay":0,"changeRate":-0.0294,"floatShares":468000000,"shares":468000000,"eps":0.2352,"marketStatus":"已收盘","change":-0.64,"latestTime":"05-21 15:00:00","open":21.8,"high":22.05,"low":21.09,"amount":216000000,"amplitude":0.0441,"askPrice":21.15,"askSize":266,"bidPrice":21.13,"bidSize":22,"shortable":0,"etf":0,"ttmEps":0.2352,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779413400000},"marketStatusCode":5,"adr":0,"adjPreClose":21.78,"symbolType":"stock","openAndCloseTimeList":[[1779327000000,1779334200000],[1779339600000,1779346800000]],"highLimit":23.96,"lowLimit":19.6,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":467948890,"isCdr":false,"pbRate":2.66,"roa":"--","peRate":89.880952,"roe":"0.65%","epsLYR":0.25,"committee":-0.204938,"marketValue":9892000000,"turnoverRate":0.0213,"status":1,"floatMarketCap":9889000000},"requestUrl":"/m/hq/s/600645","defaultTab":"news","newsList":[{"id":"2636837198","title":"中源协和(600645)披露2025年年度股东会决议公告,5月19日股价上涨0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636837198","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636837198?lang=zh_cn&edition=full","pubTime":"2026-05-19 18:10","pubTimestamp":1779185440,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘,中源协和报收于22.48元,较前一交易日上涨0.9%,最新总市值为105.19亿元。中源协和细胞基因工程股份有限公司于2026年5月18日召开2025年年度股东会,审议通过了《公司2025年度董事会工作报告》《公司2025年度利润分配预案》等议案。出席会议股东所持表决权股份占公司总股本的23.5768%,所有议案均获通过,无否决议案。北京国枫律师事务所对本次会议出具法律意见书,认为会议合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900034936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","BK0216","BK0042","600645","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636402944","title":"中源协和(600645)披露归还临时补充流动资金的募集资金公告,5月18日股价下跌1.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636402944","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636402944?lang=zh_cn&edition=full","pubTime":"2026-05-18 17:30","pubTimestamp":1779096637,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘,中源协和报收于22.28元,较前一交易日下跌1.81%,最新总市值为104.26亿元。近日,中源协和细胞基因工程股份有限公司发布《关于归还临时补充流动资金的募集资金的公告》。截至2026年5月15日,公司已将临时补充流动资金的18,000万元全部归还至募集资金专项账户,并通知了保荐机构及保荐代表人,归还金额为18,000万元,尚未归还金额为0,使用期限未超过12个月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800026291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","BK0216","BK0239","BK0042","600645"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636061834","title":"每周股票复盘:中源协和(600645)将召开2025年年度股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2636061834","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636061834?lang=zh_cn&edition=full","pubTime":"2026-05-17 01:36","pubTimestamp":1778952973,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,中源协和报收于22.69元,较上周的24.85元下跌8.69%。本周,中源协和5月11日盘中最高价报25.25元。公司公告汇总中源协和细胞基因工程股份有限公司将于2026年5月18日召开2025年年度股东会,会议采取现场投票与网络投票相结合方式。中源协和细胞基因工程股份有限公司于2025年5月20日召开董事会及监事会会议,审议通过使用不超过1.8亿元闲置募集资金暂时补充流动资金,使用期限不超过12个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700000264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0216","BK0042","BK0046","600645"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635786877","title":"中源协和(600645)披露2025年年度股东会召开提示性公告,5月13日股价上涨0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635786877","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635786877?lang=zh_cn&edition=full","pubTime":"2026-05-13 18:52","pubTimestamp":1778669554,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘,中源协和报收于24.35元,较前一交易日上涨0.12%,最新总市值为113.95亿元。该股当日开盘24.4元,最高24.55元,最低24.0元,成交额达1.83亿元,换手率为1.61%。中源协和细胞基因工程股份有限公司于近日发布《关于召开2025年年度股东会的提示性公告》。公告显示,公司定于2026年5月18日召开2025年年度股东会,会议采取现场投票与网络投票相结合方式。股权登记日为2026年5月11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300035999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600645","BK0042","BK0216","BK0046","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630679283","title":"中源协和(600645)披露关于计提资产减值损失的公告,4月27日股价下跌2.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630679283","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630679283?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:23","pubTimestamp":1777285413,"startTime":"0","endTime":"0","summary":"截至2026年4月27日收盘,中源协和报收于26.53元,较前一交易日下跌2.07%,最新总市值为124.15亿元。中源协和细胞基因工程股份有限公司于2026年4月25日发布《关于计提资产减值损失的公告》。公告显示,公司于2026年4月24日召开董事会,审议通过计提资产减值损失的议案。公司2025年度合计计提减值损失38,889,136.75元,收回或转回已计提减值损失1,805,457.76元,转销或核销4,772,523.85元。其中应收账款计提23,348,983.30元,存货跌价损失计提15,210,879.08元。本次计提减少公司2025年度利润37,083,678.99元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700034226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600645","BK0042","BK0216","BK0046","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630807661","title":"中源协和(600645)2026年一季报简析:净利润同比下降13.5%,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2630807661","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630807661?lang=zh_cn&edition=full","pubTime":"2026-04-26 06:08","pubTimestamp":1777154890,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期中源协和发布2026年一季报。截至本报告期末,公司营业总收入3.17亿元,同比下降9.54%,归母净利润2424.49万元,同比下降13.5%。本报告期中源协和盈利能力上升,毛利率同比增幅1.83%,净利率同比增幅4.5%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600002819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600645"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630080180","title":"每周股票复盘:中源协和(600645)一季度净利降13.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630080180","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630080180?lang=zh_cn&edition=full","pubTime":"2026-04-26 02:02","pubTimestamp":1777140137,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,中源协和报收于27.09元,较上周的28.32元下跌4.34%。本周,中源协和4月20日盘中最高价报28.88元。本周关注点来自业绩披露要点:中源协和2026年一季报显示,归母净利润2424.49万元,同比下降13.5%。股本股东变化截至2026年3月31日,中源协和股东户数为3.97万户,较2025年12月31日增加4359户,增幅12.34%。中源协和2025年度计提资产减值损失合计38,889,136.75元,其中应收账款计提23,348,983.30元,存货跌价损失计提15,210,879.08元,减少当年利润37,083,678.99元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600000622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0042","BK0216","BK0046","600645","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630870851","title":"中源协和(600645)3月31日股东户数3.97万户,较上期增加12.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630870851","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630870851?lang=zh_cn&edition=full","pubTime":"2026-04-25 17:03","pubTimestamp":1777107835,"startTime":"0","endTime":"0","summary":"证券之星消息,近日中源协和披露,截至2026年3月31日公司股东户数为3.97万户,较12月31日增加4359.0户,增幅为12.34%。在医疗器械行业个股中,中源协和股东户数高于行业平均水平,截至3月31日,医疗器械行业平均股东户数为2.19万户。从股价来看,2025年12月31日至2026年3月31日,中源协和区间涨幅为22.62%,在此期间股东户数增加4359.0户,增幅为12.34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500031947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","BK0188","BK0239","BK0216","600645"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630211608","title":"图解中源协和年报:第四季度单季净利润同比增长117.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630211608","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630211608?lang=zh_cn&edition=full","pubTime":"2026-04-25 02:00","pubTimestamp":1777053645,"startTime":"0","endTime":"0","summary":"证券之星消息,中源协和2025年年报显示,当年度公司主营收入14.55亿元,同比下降8.23%;归母净利润1.14亿元,同比上升13.43%;扣非净利润1.03亿元,同比下降13.96%;其中2025年第四季度,公司单季度主营收入3.62亿元,同比下降4.49%;单季度归母净利润592.44万元,同比上升117.87%;单季度扣非净利润556.27万元,同比上升155.1%;负债率29.05%,投资收益-1367.3万元,财务费用-1968.67万元,毛利率69.84%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500005388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600645"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629823592","title":"中源协和最新公告:第一季度净利润同比下降13.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629823592","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629823592?lang=zh_cn&edition=full","pubTime":"2026-04-24 23:09","pubTimestamp":1777043355,"startTime":"0","endTime":"0","summary":"中源协和(600645.SH)公告称,2026年第一季度实现营业收入3.17亿元,同比下降9.54%;归属于上市公司股东的净利润为2424.49万元,同比下降13.50%。业绩变动主要系报告期受市场环境因素影响,业务量下降,导致收入同比下降所致。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400066718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600645"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629603707","title":"中源协和(600645)披露全资子公司VUM02注射液临床试验进展公告,4月21日股价下跌2.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629603707","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629603707?lang=zh_cn&edition=full","pubTime":"2026-04-21 22:07","pubTimestamp":1776780437,"startTime":"0","endTime":"0","summary":"截至2026年4月21日收盘,中源协和报收于27.71元,较前一交易日下跌2.87%,最新总市值为129.67亿元。该股当日开盘28.56元,最高28.56元,最低27.67元,成交额达2.52亿元,换手率为1.93%。近日,中源协和细胞基因工程股份有限公司发布《关于全资子公司VUM02注射液临床试验进展的公告》。公告显示,公司全资子公司武汉光谷中源药业有限公司自主研发的VUM02注射液用于治疗失代偿期肝硬化,已完成首例受试者入组给药,正式启动Ⅰb/Ⅱ期临床试验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100052695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0188","600645","BK0046","BK0239","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624305326","title":"异动快报:中源协和(600645)4月3日14点9分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2624305326","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624305326?lang=zh_cn&edition=full","pubTime":"2026-04-03 14:10","pubTimestamp":1775196648,"startTime":"0","endTime":"0","summary":"证券之星4月3日盘中消息,14点9分中源协和(600645)触及跌停板。其所属行业医疗器械目前下跌。领涨股为海泰新光。该股为干细胞,医药,医疗器械概念热股。4月2日的资金流向数据方面,主力资金净流入3157.01万元,占总成交额3.33%,游资资金净流入4204.03万元,占总成交额4.44%,散户资金净流出7361.05万元,占总成交额7.77%。近5日资金流向一览见下表:中源协和主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300023157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600645","BK0042","BK0046","BK0188","BK0239","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617505251","title":"异动快报:中源协和(600645)3月6日10点9分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2617505251","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617505251?lang=zh_cn&edition=full","pubTime":"2026-03-06 10:10","pubTimestamp":1772763044,"startTime":"0","endTime":"0","summary":"证券之星3月6日盘中消息,10点9分中源协和触及涨停板。其所属行业医疗器械目前上涨。该股为干细胞,CAR-T疗法,基因编辑概念热股,当日干细胞概念上涨3.31%,CAR-T疗法概念上涨3.04%,基因编辑概念上涨2.96%。3月5日的资金流向数据方面,主力资金净流入59.12万元,占总成交额0.2%,游资资金净流入306.75万元,占总成交额1.02%,散户资金净流出365.87万元,占总成交额1.22%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600010505.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600645","BK0216","BK0046","BK0042","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616826144","title":"中源协和最新公告:子公司获医疗器械注册证产品为国内首款飞行时间质谱法肿瘤伴随诊断试剂盒","url":"https://stock-news.laohu8.com/highlight/detail?id=2616826144","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616826144?lang=zh_cn&edition=full","pubTime":"2026-03-01 16:31","pubTimestamp":1772353872,"startTime":"0","endTime":"0","summary":"中源协和(600645.SH)公告称,控股子公司近日获得国家药监局颁发的医疗器械注册证(III类),产品为人EGFR/KRAS/BRAF/ERBB2/PIK3CA基因突变检测试剂盒(飞行时间质谱法),该产品是国内首款基于飞行时间质谱法获批上市的肿瘤伴随诊断试剂盒,用于非小细胞肺癌、结直肠癌患者的基因变异检测及相关药物伴随诊断,相关药物已纳入国家医保目录。产品获批丰富了公司肿瘤伴随诊断产品线,对公司未来业绩的影响尚无法预测。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100004439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1222","BK0042","BK0188","BK0046","09997","BK1100","159883","BK0239","BK1574","09996","BK0216","BK1583","600645"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601100590","title":"1月5日中源协和涨6.11%,银河医药混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601100590","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601100590?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:32","pubTimestamp":1767598330,"startTime":"0","endTime":"0","summary":"证券之星消息,1月5日中源协和涨6.11%,收盘报26.74元,换手率4.03%,成交量18.84万手,成交额4.93亿元。融资融券方面近5日融资净流出3316.55万,融资余额减少;融券净流出3.68万,融券余额减少。重仓中源协和的公募基金请见下表:根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为银河基金的银河医药混合A。银河医药混合A目前规模为5.03亿元,最新净值0.5584,较上一交易日下跌0.16%,近一年上涨13.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1574","09939","BK1161","BK1515","BK0046","BK0188","BK0042","600645","BK0239","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595449728","title":"中国生物科技服务引入战略投资者龚虹嘉先生 开启产业协同与二次增长新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=2595449728","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595449728?lang=zh_cn&edition=full","pubTime":"2025-12-31 12:42","pubTimestamp":1767156120,"startTime":"0","endTime":"0","summary":"12月30日,中国生物科技服务(08037)董事会正式公告,拟通过特别授权向知名投资人龚虹嘉先生控股的富策控股发行3500万美元(约合2.72亿港币)4年期可转换债券。这一交易绝非单纯的财务融资行为 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20251231/c673663735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["002415","BK0175","BK0046","BK0196","BK0239","BK0216","BK0188","BK0010","BK0197","BK0214","600645","BK0028","BK0100","BK0042","BK0058","BK0183","BK0041","BK0089"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594230624","title":"中源协和(600645)披露募投项目延期公告,12月25日股价上涨1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594230624","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594230624?lang=zh_cn&edition=full","pubTime":"2025-12-25 23:08","pubTimestamp":1766675301,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘,中源协和报收于25.72元,较前一交易日上涨1.02%,最新总市值为120.36亿元。该股当日开盘25.5元,最高25.82元,最低25.31元,成交额达1.62亿元,换手率为1.35%。公司近日发布公告称,对募投项目“肿瘤标志物类诊断试剂开发项目”达到预定可使用状态的时间进行延期,由原计划的2025年12月延期至2026年12月。项目实施主体、实施方式及投资金额未发生变更。该事项已经公司董事会审议通过,独立财务顾问对此无异议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500036656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600645","BK0188","BK0046","BK0239","BK0042","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594365022","title":"中源协和最新公告:终止与中国科学院大学教育基金会捐赠协议并解除合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2594365022","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594365022?lang=zh_cn&edition=full","pubTime":"2025-12-25 17:49","pubTimestamp":1766656187,"startTime":"0","endTime":"0","summary":"中源协和(600645.SH)公告称,公司已与中国科学院大学教育基金会签署《捐赠终止协议》,终止了双方于2021年8月31日签署的《捐赠协议书》。原协议约定的除已到账捐赠款780万元外,剩余未到账捐赠款不再进行捐赠。此外,公司还与中国科学院大学签署了《关于继续出资承办“中源协和生命医学奖”之合作协议书》之解除协议,自协议生效之日起解除双方于2021年签署的合作协议。终止捐赠不会对公司经营和财务状况产生重大影响,公司正在筛选新的合作方以重启中源协和生命医学奖。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500026905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","600645","BK0239","BK0046","BK0042","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586255142","title":"中源协和(600645)披露拟取消监事会并修订公司章程,11月27日股价下跌0.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586255142","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586255142?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:10","pubTimestamp":1764252644,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘,中源协和报收于28.48元,较前一交易日下跌0.04%,最新总市值为133.27亿元。该股当日开盘28.83元,最高29.28元,最低28.46元,成交额达3.83亿元,换手率为2.84%。公司近日发布公告称,将于2025年12月15日召开2025年第二次临时股东大会,会议将采取现场与网络投票相结合的方式进行,网络投票通过上海证券交易所系统开展。本次会议共审议九项议案,包括取消监事会并修订公司章程、修订多项内部治理制度等事项,其中前四项为特别决议议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0216","BK0046","BK0042","600645","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585945911","title":"11月24日中源协和涨10.02%,银河医药混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585945911","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585945911?lang=zh_cn&edition=full","pubTime":"2025-11-24 15:32","pubTimestamp":1763969555,"startTime":"0","endTime":"0","summary":"证券之星消息,11月24日中源协和涨10.02%,收盘报28.23元,换手率3.61%,成交量16.91万手,成交额4.68亿元。重仓中源协和的公募基金请见下表:根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为银河基金的银河医药混合A。银河医药混合A目前规模为5.03亿元,最新净值0.5595,较上一交易日下跌2.68%,近一年上涨5.01%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400012984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600645","BK0046","BK1515","BK1161","BK0188","159938","09939","BK1574","BK0216","BK0042","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779381999437,"stockEarnings":[{"period":"1week","weight":-0.0981},{"period":"1month","weight":-0.2371},{"period":"3month","weight":-0.1544},{"period":"6month","weight":-0.1761},{"period":"1year","weight":-0.0575},{"period":"ytd","weight":-0.1611}],"compareEarnings":[{"period":"1week","weight":-0.0241},{"period":"1month","weight":-0.0019},{"period":"3month","weight":-0.0012},{"period":"6month","weight":0.0632},{"period":"1year","weight":0.2036},{"period":"ytd","weight":0.0273}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"中源协和细胞基因工程股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"39684人(较上一季度增加12.34%)","perCapita":"11787股","listingDate":"1993-05-04","address":"天津市西青区滨海高新区华苑产业区梅苑路12号【A】座二层房屋","registeredCapital":"46794万元","survey":" 中源协和细胞基因工程股份有限公司的主营业务是“精准预防”领域的细胞检测制备及存储;“精准诊断”领域的体外诊断原料、体外诊断试剂和器械的研产销,生物基因、蛋白、抗体等科研试剂产品,以及基因检测服务;“细胞治疗”领域的干细胞、免疫细胞临床应用的研发。公司的主要产品是细胞检测制备及存储、基因检测、科研试剂、检测试剂。","listedPrice":50},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中源协和(600645)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中源协和(600645)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中源协和,600645,中源协和股票,中源协和股票老虎,中源协和股票老虎国际,中源协和行情,中源协和股票行情,中源协和股价,中源协和股市,中源协和股票价格,中源协和股票交易,中源协和股票购买,中源协和股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中源协和(600645)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中源协和(600645)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}